Supplementary
Primer Sequence (5`-3`) 
VP35-F CGGAATTCCGATGACAACTAGAACAAAGGGCAGGG VP35-R GCGTCGACGCAAATTTTGAGTCCAAGTGTTTTACC ZIKV NS3-F CGGAATTCATGAGTGGTGCTCTATGGGATGTGCCTGCT ZIKV NS3-R TTGCGGCCGCTTATCTTTTCCCAGCGGCAAACTCCTTG VP35-△IID-F GAAAATTTTGGGAAACCTTAATAATAATCGGC VP35-△IID-R CCTTTGCCGATTATTATTAAGGTTTCCCAAAATTTTC VP35-RKR/AAA-F GGTGACATTCCCGCGGCTTGCCAGGCGAGCTTGGC GCCAGTCCCACCATC VP35-RKR/AAA-R GATGGTGGGACTGGCGCCAAGCTCGCCTGGCAAGC CGCGGGAATGTCACC

△1-50-F CGGAATTCATGCCAGGATTATGCTACGCATCCCAAATGC
△1-50-R GCGTCGACTCAAATTTTGAGTCCAAGTGTTTTA
△137-173-F CTCCTCATTGAACAGGGTTTGTGCTTCACTTTATGAAGAAAG
△137-173-R CTTACCCCGAATCGCACTTTCTTCATAAAGTGAAGCACAAAC
△209-224-F CAACAATCTAGACAGTACCACTTCAAGAAACATTATGTATG
△209-224-R CCAGGCAAGTGATCATACATAATGTTTCTTGAAGTGGTAC
△263-278-F GGACATTATTCATGCTGAGCAAATTACAAAAAGAGTTCC
Supplementary Figure Legends
Supplementary Figure S1 . Expression of recombinant EBOV VP35. The purified MBP alone and MBP-fusion VP35 were subjected to 10% SDS-PAGE followed by Coomassie brilliant blue R250 staining. Lane 1, protein marker.
Supplementary Figure S2 . Size exclusion chromatography of recombinant EBOV VP35. (A)
The MBP-VP35 was purified via MBP column and ion-exchange, and then was examined by 10% SDS-PAGE and Coomassie brilliant blue R250 staining. (B) The purified MBP-VP35 was subjected to the size exclusion chromatography by using a Superdex 200 increase 10/300GL
column. Protein elution was followed by UV detection at 280 nm. X axis represents the elution volume (in ml). The major peak comprised most protein (MBP-VP35) that was eluted as a molecular mass of ~600 kDa. The peak of monomeric BSA (~67 kDa) was shown as control.
Supplementary Figure S3 . The NTPase activity of MBP-VP35 purified via the ion-exchange and size exclusion chromatography was measured as nanomoles of released inorganic phosphate by using a sensitive colorimetric assay.
Supplementary Figure S4 . EBOV VP35 has dsRNA-binding activity. (A) Gel mobility shift assays were performed to evaluate the dsRNA-binding activity of MBP-VP35.
MBP-VP35 was incubated with 0.1 pmol DIG-labelled dsRNA substrate, and the complex was VP35 by using the PSIPRED server. Yellow, β-strand; purple, α-helix; grey, coil or loop.
Supplementary Figure S8 . The critical residues for dsRNA binding in the X-ray structure of EBOV VP35 IID. The crystal structure of EBOV VP35 (PDB ID: 3L28) on Protein Data Bank was used for analysis. All presentations of molecular structure graphics were created by using the PyMOL molecular visualization system (The PyMOL Molecular Graphics System). The critical residues for VP35 dsRNA-binding are labeled in yellow.
Supplementary Figure S9 . Expression of recombinant EBOV VP35 and its mutants. The WT, ΔIID and RKR/AAA MBP-VP35 were subjected to 10% SDS-PAGE and Coomassie brilliant blue R250 staining.
Supplementary Figure S10 . EBOV VP35 is associated with dsRNA in human 293T cells.
HEK293T cells expressing the dsRNA of EBOV 3'-UTR1-200 together with the Flag-tagged WT or mutant VP35 (WT and RKR/AAA) were subjected to RNA-IP by using anti-Flag antibody.
Northern and Western blots were performed to detect the precipitated proteins and their bound RNAs, respectively. The DIG-labelled positive-stranded RNA of EBOV 3'-UTR1-200 was used as probe.
Supplementary Figure S11 . GuHCl showed no effect on the viral protein expression and IFN 
